Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of Medical Imaging and Radiation Oncology
|
February 2, 2022
Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria
Tamara Fogarty, Mark Tacey, Giulia McCorkell, et al.
Rapid Communications in Mass Spectrometry : RCM
|
January 15, 2026
GC-MS of Some Haemanthamine- and Crinine-Type Amaryllidaceae Alkaloids
Strahil Berkov, Rumen Denev, David Kok, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Scalable Production of Extracellular Vesicles and Its Therapeutic Values: A Review
Chiew Yong Ng, Li Ting Kee, Maimonah Eissa Al-Masawa, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2021
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
Peter Kar Han Lau, Breon Feran, Lorey Smith, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of Medical Imaging and Radiation Oncology
|
February 2, 2022
Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria
Tamara Fogarty, Mark Tacey, Giulia McCorkell, et al.
Rapid Communications in Mass Spectrometry : RCM
|
January 15, 2026
GC-MS of Some Haemanthamine- and Crinine-Type Amaryllidaceae Alkaloids
Strahil Berkov, Rumen Denev, David Kok, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Scalable Production of Extracellular Vesicles and Its Therapeutic Values: A Review
Chiew Yong Ng, Li Ting Kee, Maimonah Eissa Al-Masawa, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2021
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
Peter Kar Han Lau, Breon Feran, Lorey Smith, et al.
Page
of 2